Security National Bank of So Dak’s Sarepta Therapeutics SRPT Stock Holding History

Security National Bank of So Dak’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,000	Closed	-$243K	–	116
2024 Q4	$243K	Hold	2,000	–	–	0.14%	97
2024 Q3	$250K	Hold	2,000	–	–	0.14%	89
2024 Q2	$316K	Hold	2,000	–	–	0.19%	84
2024 Q1	$259K	Buy	+2,000	New	+$245K	0.16%	90
2023 Q4	–	Sell	-2,000	Closed	-$242K	–	100
2023 Q3	$242K	Hold	2,000	–	–	0.18%	90
2023 Q2	$229K	Buy	+2,000	New	+$258K	0.16%	93
2022 Q4	$259K	Hold	2,000	–	–	0.19%	87
2022 Q3	$221K	Buy	+2,000	New	+$202K	0.2%	84

Other funds holding SRPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Security National Bank of So Dak's SRPT Position: Q1 2025 in Review

Security National Bank of So Dak sold out of Sarepta Therapeutics (SRPT) in Q1 2025, closing a stake of 2,000 shares — an estimated $243K sold.

Security National Bank of So Dak first reported a position in SRPT in Q3 2022 and held it in 8 quarters. The position peaked at $316K in Q2 2024. 431 funds tracked by Wall St. Rank hold SRPT as of Q1 2025.

Security National Bank of So Dak reported no remaining Sarepta Therapeutics position as of Q1 2025 after selling out during the quarter.
Security National Bank of So Dak sold 2,000 Sarepta Therapeutics shares in Q1 2025, an estimated $243K.
Security National Bank of So Dak first reported a position in Sarepta Therapeutics in Q3 2022 and held it in 8 quarters.
Security National Bank of So Dak's Sarepta Therapeutics position peaked at $316K in Q2 2024.
431 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2025.

Based on Security National Bank of So Dak's 13F filing for Q1 2025, filed 29 Apr 2025.